Literature DB >> 8152814

Guanine-rich (GGNNGG) elements at chromosomal breakpoints interact with a loop-forming, single-stranded DNA-binding protein.

S Knapp1, G Delle Karth, J Friedl, B Purtscher, G Mitterbauer, P H Domer, U Jaeger.   

Abstract

Proto-oncogene-activation is frequently preceded by chromosomal translocations. Several models suggest that DNA single-strands and loops may serve as intermediates in the process of illegitimate recombination. Guanine-rich, repetitive elements are preferred sites of chromosomal exchange and can undergo conformational changes which result in the generation of single-stranded DNA. Here we describe a single-stranded DNA-binding protein which binds specifically to guanine-rich elements at the breakpoints of human reciprocal translocations, including the t(14;18), t(2;8), t(9;22), t(15;17) and t(4;11) in leukemia and lymphoma. The primitive binding consensus consists of two guanine-residues on either side separated by a spacer of at least two nucleotides (GGN-NGG). Binding activity is unaltered by a spacer length of up to 46 nucleotides. These data suggest that the protein has the unique ability to form or stabilize DNA-loops and may thus play a general role in recombination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152814

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

1.  The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.

Authors:  A Greco; C Mariani; C Miranda; A Lupas; S Pagliardini; M Pomati; M A Pierotti
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

2.  Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent.

Authors:  Surendra K Prajapati; Anju Verma; Tridibes Adak; Rajpal S Yadav; Ashwini Kumar; Alex Eapen; Manoj K Das; Neeru Singh; Surya K Sharma; Moshahid A Rizvi; Aditya P Dash; Hema Joshi
Journal:  Malar J       Date:  2006-10-24       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.